Saudi Arabia, Pfizer to Set Up Platform for Vaccine Research

Saudi Arabia and Pfizer agreed to establish a platform for research and development of vaccines, Saudi ministry of industry said in a statement.

• The investment ministry also signed an accord with AstraZeneca that will explore opportunities to establish clinical research centers in the Kingdom
• NOTE: Saudi Arabia to Manufacture Coronavirus Vaccines Locally: Asharq

To contact the reporter on this story:
Zaid Sabah in Washington at zalhamid@bloomberg.net

To contact the editors responsible for this story:
Nayla Razzouk at nrazzouk2@bloomberg.net

Hari Govind

© 2021 Bloomberg L.P. All rights reserved. Used with permission.